Stimulation and resection of Vidian nerve in patients with chronic hypertrophic non-allergic rhinitis: effect on histamine content in nasal mucosa

1986 ◽  
Vol 18 (1-2) ◽  
pp. 251-253 ◽  
Author(s):  
Emanuela Masini ◽  
L. Rucci ◽  
Maria Bruna Cirri-Borghi ◽  
Eliana Giannella ◽  
P. F. Mannaioni
2002 ◽  
Vol 109 (1) ◽  
pp. S98-S98
Author(s):  
Alan Wolff ◽  
Kumar Patel ◽  
John Oppenheimer ◽  
Stan H Weiss ◽  
Leonard Bielory

2015 ◽  
Vol 273 (6) ◽  
pp. 1469-1475 ◽  
Author(s):  
Sven Becker ◽  
Julia Rasp ◽  
Katharina Eder ◽  
Alexander Berghaus ◽  
Matthias F. Kramer ◽  
...  

2015 ◽  
Vol 12 (4) ◽  
pp. 3-7
Author(s):  
V A Utesheva ◽  
G P Bondareva ◽  
A I Kryukov ◽  
T G Barkhina

Nonallergic rhinitis with eosinophilia syndrome (NARES) is a syndrome containing the symptoms similar to allergic rhinitis, with absence of atopy and the presence of eosinophila more than 20% in smears from nasal mucosa. Pathophysiology of NARES has not been studied completely, but permanent eosinophilic inflammation is the keystone of NARES pathogenesis. This disease is marked by local eosinophilic infiltration without atopy, confirmed by negative skin tests, normal levels of total and specific IgE in serum, negative nasal provocation tests with allergens. Nowadays this nosology is considered to be poorly understood.


1989 ◽  
Vol 28 (3-4) ◽  
pp. 224-230 ◽  
Author(s):  
L. Rucci ◽  
E. Masini ◽  
R. Arbi Riccardi ◽  
E. Giannella ◽  
C. Fioretti ◽  
...  

2011 ◽  
Vol 127 (2) ◽  
pp. AB52-AB52
Author(s):  
J. Kennedy ◽  
P. Chen ◽  
S. Payne ◽  
J. Steinke ◽  
L. Borish

ORL ◽  
2021 ◽  
pp. 1-6
Author(s):  
Giancarlo Pecorari ◽  
Giuseppe Riva ◽  
Claudia Bartoli ◽  
Mattia Ravera ◽  
Valeria Dell’Era ◽  
...  

Introduction: Radiofrequency turbinate volume reduction (RFTVR) is an effective treatment of inferior turbinate hypertrophy. RFTVR can reduce epithelial cell alterations in nasal mucosa. The aim of this observational study was to evaluate the effects of RFTVR on nasal obstruction and cytology, stratifying for different types of rhinitis. Methods: Nasal cytology and subjective nasal obstruction were evaluated on 113 patients before RFTVR (T0) and after 3 months (T1). The patients were divided into groups on the basis of the underlying disease: allergic rhinitis, nonallergic rhinitis, rhinitis medicamentosa, and other diseases (e.g., hormonal-based turbinate hypertrophy). Results: Nasal cytology at T0 identified 42 patients with allergic rhinitis, 40 with nonallergic rhinitis, 19 with rhinitis medicamentosa, and 12 with other diseases. An improvement of nasal cytology at T1 was observed in 29.2% of cases. They mainly consisted of patients with nonallergic rhinitis with neutrophils, whose neutrophil infiltrate decreased. Only 2 cases (1.7%) showed a worsening of nasal cytology at T1. A statistically significant decrease in subjective nasal obstruction was observed for every group (p < 0.05). Higher differences of nasal obstruction between T0 and T1 were found in patients with rhinitis medicamentosa or other diseases. Conclusion: RFTVR represents a safe and effective treatment for turbinate hypertrophy of various etiology. It is not responsible for a worsening of inflammatory infiltrate of the nasal mucosa.


Sign in / Sign up

Export Citation Format

Share Document